Acta Rheumatologica

  • Journal h-index: 2
  • Journal CiteScore: 0.29
  • Journal Impact Factor: 0.67
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • OCLC- WorldCat
  • Publons
  • Google Scholar
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Review Article - (2023) Volume 10, Issue 2

Effective treatment with exercise for those who experiences ankylosing spondylitis

Razieh A Khan*
Cardiac Rehabilitation Institute, Leviev Heart Center, Sheba Medical Center, United States
*Correspondence: Razieh A Khan, Cardiac Rehabilitation Institute, Leviev Heart Center, Sheba Medical Center, United States, Email:

Received: 30-Mar-2023, Manuscript No. ipar-23-13709; Editor assigned: 01-Apr-2023, Pre QC No. ipar-23-13709(PQ); Reviewed: 15-Apr-2023, QC No. ipar-23-13709; Revised: 20-Apr-2023, Manuscript No. ipar-23-13709(R); Published: 27-Apr-2023, DOI: 10.36648/ipar.


There is a lack of detailed information to guide exercise prescription, including the type and dosage of exercise required for the greatest benefit, despite Level 1b evidence and international consensus that exercise is beneficial in ankylosing spondylitis. This cooperative undertaking, consolidating proof with clinical ability, was laid out to foster functional proposals to direct feasible activity solution for people with AS.

Utilizing a changed Delphi strategy, 10 clinical inquiries were produced and an orderly writing survey was directed for each. Based on the integration of evidence summaries and expert opinion, draft recommendations were developed during a two-day meeting. Prior to finalization, patient and health professional groups provided feedback. For the following areas, recommendations and practice points were created: assessment; monitoring; safety; infection the board; exercise tailored to the AS; sporting activities; setting, dosage, and adherence. A framework for exercise in other chronic musculoskeletal conditions was developed. The feedback suggests that the final consensus statement contains information that is helpful to those attempting to provide exercise prescriptions for AS patients based on best practices.

The recommendations offer an up-to-date, evidence-based approach to the entire range of issues associated with the use of exercise in AS and highlight evidence gaps that call for additional investigation. Most importantly, this includes looking into the aspects of exercise program design that are necessary to produce the greatest effect, long-term exercise program adherence, and the particular exercise requirements of AS subgroups. To achieve optimal exercise outcomes, the guidelines must be widely disseminated and implemented.


People with ankylosing spondylitis experience agony and solidness, which essentially influences the pivotal skeleton. Since the condition is a fiery joint inflammation, weakness can likewise be an unmistakable side effect. Enthesitis, or inflammation of the anatomical region of the bony attachment of tendons, ligaments, or joint capsules, is the primary pathology. This usually happens in the spine; if unrestrained, new bone arrangement might bring about ankylosis, or spinal combination. Since onset occurs most frequently in early adulthood, AS can have a significant lifetime impact on an individual. Anecdotally, exercise appears to be more effective than other forms of arthritis in treating this condition, so it has traditionally been treated with a combination of anti-inflammatory medications and exercise [1].

In spite of the fact that practice suggestions highlight noticeably in pertinent clinical rules for the administration of ankylosing spondylitis, and are upheld by a collection of blended quality proof, in clinical practice there is an absence of explicit data to direct activity arranging [2]. Most of distributed proof spotlights on portability work out, and somewhat little consideration has been given to different parts of activity program configuration like reinforcing, balance or cardio-respiratory activity, regardless of acknowledgment that AS can influence muscle strength, balance and cardio-respiratory capability. Similarly, there is a lack of information regarding dosage and program adherence. A few preliminaries depend on concentrated, time-restricted (frequently private) practice modalities, which are not promptly accessible in numerous districts like in-patient recovery or spa treatment/practice blends. Last but not least, recent rapid advancements in medical management, such as the tighter control of disease activity through the use of anti-tumour necrosis factoralpha agents, have raised concerns regarding the continued significance of exercise in the treatment of AS [3].

As a result, it remains challenging to create an exercise program for a person or group with AS that is optimally effective, evidence-based, and long-lasting. The general goal of this venture was to foster more unambiguous suggestions covering a scope of points which should be considered for practice solution fundamentally for use by wellbeing experts, yet in addition for individuals with AS who might wish to get more itemized data about the utilization of activity as a self-administration technique [4].


The first comprehensive set of exercise recommendations to guide practitioners' exercise prescription in AS is provided in this consensus statement. We developed a framework for taking into account all clinically relevant aspects of exercise prescription for AS patients through the consensus process. This framework has the potential to be adapted to other chronic musculoskeletal conditions, such as osteoporosis or osteoarthritis [5].

The cycle we followed had various qualities and impediments. The WG got significant experience and mastery the clinical utilization of practice in AS, and the improvement of key point regions worked with the examination of the multitude of significant features of activity solution in a manner that has not been recently endeavoured. In any case, there were likewise a few limits to the review [6]. Only papers written in English were taken into consideration for practical reasons, and papers were initially chosen by just one author; however, a second author independently checked the included papers for suitability. There were no studies of people who had axial spondyloarthritis, so more research on this group might be helpful in the future. Even though one of the WG members has AS, and additional patient input was obtained after the draft recommendations were developed, including people with AS earlier in the process could have strengthened this process. In addition to physiotherapy, other professions are involved in exercise prescription. In future reviews, expanding the representation on the WG might be considered [7]. Although the HP survey's results were comparable to those of external validity testing for other rheumatology recommendations, it's possible that having a wider range of participants helped the feedback process. Last but not least, non-pharmacological treatments like joint mobilization and exercise can be used in conjunction with one another in clinical practice; however, the investigation of such treatment combinations was beyond the scope of this review.

Consolidating efficient surveys with agreement suggestions is an extended cycle. The review for AS-specific publications was repeated up until July 1, 2015, in order to address the delay between the initial searches and publication. The criteria for inclusion were met by seven RCTs and five SRs. In terms of support for exercise for improved outcomes, the SRs gave the recommendations more weight [8]. More specifically, "multi-modal" programs were supported; cardio-vascular preparation and the synergistic impact of activity and hostile to TNFα prescription. There was initial evidence to support: McKenzie" in individuals with early AS, inspiratory muscle training, and aquatic exercise in individuals with more advanced disease. However, "the most effective exercise protocol remains unclear" was the consensus. We believe that future exercise recommendations would be more specific if additional studies focused on subgroups like early or later AS were conducted; however, the fundamental framework will apply to everyone [9]. With respect to practice settings and management, a SR of locally situated practice found little to direct advantages for torment, capability, sickness action and wretchedness. However, a 12-month follow-up to an RCT, and a large multicentre trial in Portugal found only small, measureable gains for a program that included little supervised exercise practice. An additional PP has been added to reflect these findings.

Major concerns regarding trial quality and clinical relevance persist, as previous authors have noted. In general, future trials should use validated objective measures like the BASMI 10-point scale and better describe the exercise interventions and dosage. Notwithstanding reliable discoveries that exercise is viable in AS, the likely connections between the physiological impacts of activity and the neurotic cycles still can't seem to be explained. More information about this could work with exact focusing of activity impacts by more educated program plan. The effectiveness of stratifying patient groups could be determined through investigation of various patient groups: It appears unlikely that "one size fits all" will ever exist. Further assessment of the impact of explicit projects to address strength, cardiorespiratory and useful elements, is likewise justified [10]. The design of exercise programs should also be clearly connected to the goals of the treatment and address physiological effectiveness, as well as progression: Due to the fact that some subjects may have a low baseline, longer studies are required. Programs of this kind would make it easier to fine-tune dosages, which may account for the larger effect sizes that AS patients and doctors frequently report. Precise actual work trackers should in future give better genuine information on practice measurement, and studies that consider long haul results and self-administration methodologies would be more pertinent to the truth of restricted accessibility of assets. Lastly, this would provide a better understanding of the most urgently required area of research, which is long-term exercise strategy adherence, as identified in this review.


Although the evidence was of varying quality, it consistently supported exercise's beneficial effects on AS. The current strategy, on the other hand, continues to be individualized and tailored to each patient's therapeutic objectives due to lower-quality research in some areas. The ten recommendations are flexible enough to be adapted to each individual's needs while remaining specific enough to be useful in the clinical setting. Even though the recommendations were created for the Australian context, they would be useful for anyone looking for information on long-term exercise strategies or in areas where spas or residential centers are not typically available. To ensure a more consistent approach to AS exercise management and optimize outcomes for people with this condition, it will be important for the guidelines to be widely distributed and implemented.


  1. Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998; 22(12): 1501-1511.
  2. Indexed at, Google Scholar, Crossref

  3. Cranshaw I, Gikas P, Fisher C. Clinical outcomes of extra- thoracic solitary fibrous tumours. Eur J Surg Oncol. 2009; 35(9): 994-998.
  4. Indexed at, Google Scholar, Crossref

  5. Demicco EG, Park MS, Araujo DM. Solitary fibrous tumor: a clinic pathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012; 25(9): 1298-1306.
  6. Indexed at, Google Scholar, Crossref

  7. Park MS, Patel SR, Ludwig JA. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011; 117(21): 4939-4947.
  8. Indexed at, Google Scholar, Crossref

  9. Roughley PJ, Mort JS. The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop. 2014; 1(1): 8.
  10. Indexed at, Google Scholar, Crossref

  11. Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol. 2011; 2011: 969012.
  12. Indexed at, Google Scholar, Crossref

  13. Imagawa K, de Andrés MC, Hashimoto K, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes-implications for osteoarthritis. Biochem Biophys Res Commun. 2011; 405(3): 362-367.
  14. Indexed at, Google Scholar, Crossref

  15. Jones IA, Togashi R, Wilson ML, et al. (2019) Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019; 15(2): 77-90.
  16. Indexed at, Google Scholar, Crossref

  17. Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999; 164(2): 85-91.
  18. Indexed at, Google Scholar, Crossref

  19. Houpt JB, McMillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol. 1999; 26(11): 2423-30.
  20. Indexed at, Google Scholar, Crossref